HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

United States

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey

Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown, New Jersey

Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale, New Jersey

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack, New York

Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison, New York

Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York, New York

Memorial Sloan Kettering at Nassau (Limited Protocol Activities), Uniondale, New York